CAS: 897776-15-7

Methyl (3-phenyl-1H-indazol-1-yl)acetate is a synthetic organic compound, often studied for its potential roles in pharmaceutical development. It is derived through organic synthesis involving indazole derivatives, which are commonly utilized in the design of bioactive molecules. The compound features a structural framework that includes a phenyl group and an indazole moiety, making it a candidate for the development of drugs targeting specific biological pathways. Its mode of action typically involves interaction with biological receptors or enzymes, modulating their activity. The uses and applications of Methyl (3-phenyl-1H-indazol-1-yl)acetate are primarily in the realm of medicinal chemistry and drug discovery. Researchers investigate its potential in various therapeutic areas, leveraging its structural attributes to explore efficacy and selectivity against specific pharmacological targets. While not yet a commercial drug, its study contributes to the broader understanding of indazole-based compounds in drug design, offering insights into new therapeutic agents and innovative treatment strategies. This compound embodies the intersection of synthetic chemistry and biological application, exemplifying the potential for small molecules to influence modern medicinal approaches.

Inz-1 is an effective and fungal-selective inhibitor of mitochondrial cytochrome bc1 with IC50s of 8.092 and 45.320 μM for yeast and human.

Inz-1